Research Project on Pharmacokinetics in Humboldt Penguins

Humboldt penguins are a threatened species. Avian malaria poses a significant health challenge for these animals. To provide targeted treatment for affected penguins, it is essential to understand how an active substance behaves in their bodies.

The Clinic for Zoo Animals, Exotic Pets and Wildlife at the Vetsuisse Faculty of the University of Zurich is therefore investigating the pharmacokinetics of tafenoquine in Humboldt penguins in collaboration with Zoo Zurich.

As part of the research project, Interlabor analysed blood plasma samples from the penguins and quantified the active substance using LC-HRMS. The study investigates how tafenoquine behaves over time in the bodies of healthy animals. Its aim is to establish a basis for targeted tafenoquine treatment in Humboldt penguins affected by the disease.

The project is led by Lara Scherer and Dr. med. vet. Maya Kummrow. The results are expected to be published in a scientific journal and contribute significantly to the long-term protection of this threatened species.

Following the laboratory work, the Interlabor team also gained insights into the care and feeding of the penguins during a visit to Zoo Zurich.

We sincerely thank the Vetsuisse Faculty of the University of Zurich and Zoo Zurich for their collaborative partnership.